6 Pulmonary Embolism Clinical Trials in Newark, OH (2026)

Q: How do I join a clinical trial in Newark?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you.

Recruiting Pulmonary Embolism Studies in Newark

NCT04774159Recruiting

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

The Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD) trial will evaluate if anti-inflammatory therapy with colchicine will reduce vascular ...

Newark, OH6,150 participantsPopulation Health Research Institute

View Study Details

NCT04798261Recruiting

Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System

The objective of this study is to evaluate real world long-term functional outcomes, safety and performance of the Indigo Aspiration System for the treatment of pulmonary embolism (PE)....

Newark, OH1,500 participantsPenumbra Inc.

View Study Details

NCT05591118Recruiting

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients wit...

Newark, OH500 participantsNYU Langone Health

View Study Details

NCT07060495Recruiting

RADA16 for Adult Tonsillectomy

The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare applica...

Newark, OH134 participantsRutgers, The State University of New Jersey

View Study Details

NCT07188779Recruiting

Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children

The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following pediatric tonsillectomy procedures. Researchers will compar...

Newark, OH134 participantsRutgers, The State University of New Jersey

View Study Details

NCT07071077Recruiting

Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling i...

Newark, OH60 participantsUniversity of Delaware

View Study Details

About Pulmonary Embolism Clinical Trials in Newark

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 6 pulmonary embolism clinical trials recruiting participants in Newark, OH. These studies are seeking a combined 8,478 participants. Research is being sponsored by Population Health Research Institute, Penumbra Inc., NYU Langone Health and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Newark — FAQ

Are there pulmonary embolism clinical trials in Newark?

Yes, there are 6 pulmonary embolism clinical trials currently recruiting in Newark, OH. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Newark?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.

Are clinical trials in Newark free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 6 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov